Imported from EML workbook.
Formulations: - Parenteral > General injections > IV: 50 mg in vial powder for injection (liposomal complex); 50 mg in vial powder for injection (as sodium deoxycholate) Indications: - Candidosis - Blastomycosis - Cryptococcosis - Coccidioidomycosis - Histoplasmosis - Sporotrichosis - Aspergillosis - Visceral leishmaniasis Source: EML workbook import
Indications: - Systemic or invasive candidosis Source: EML workbook import
Indications: - Systemic or invasive candidosis Source: EML workbook import
Formulations: - Local > Topical > Other: 1% vaginal cream; 10% vaginal cream; 100 mg vaginal tablet; 500 mg vaginal tablet Indications: - Vulvovaginal candidosis Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 2 mg per mL in vial Oral > Liquid: 50 mg per 5 mL; 50 mg per 5 mL powder for oral liquid Oral > Solid > capsule: 50 mg Indications: - Cryptococcosis - Candidosis Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 2.5 g per 250 mL infusion Oral > Solid: 250 mg capsule Indications: - Cryptococcosis Source: EML workbook import
Formulations: - Oral > Liquid: 125 mg per 5 mL Oral > Solid: 125 mg; 250 mg Indications: - Dermatophytosis Source: EML workbook import
Formulations: - Oral > Liquid: 10 mg per mL Oral > Solid: 100 mg Indications: - Chronic pulmonary aspergillosis - Chromoblastomycosis - Histoplasmosis - Talaromycosis - Sporotrichosis - Paracoccidioidomycosis Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 50 mg in vial (as sodium) powder for injection; 100 mg in vial (as sodium) powder for injection Indications: - Systemic or invasive candidosis Source: EML workbook import
Formulations: - Oral > Liquid: 100000 IU per mL Local > Topical > Other: 100000 IU pessary Oral > Solid > dosage form: 500000 IU Oral > Solid > lozenge: 100000 IU Indications: - Candidosis Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 200 mg in vial powder for injection Oral > Liquid: 40 mg per mL powder for oral liquid Oral > Solid: 50 mg tablet; 200 mg tablet Indications: - Invasive aspergillosis - Chronic pulmonary aspergillosis Source: EML workbook import
Ready to amplify your rewards? Drop your email and we'll be in touch soon.
